Site-specific integration of adeno-associated virus-based plasmid vectors in lipofected HeLa cells

Virology

Volumn 268, Issue 2, 2000, Pages 391-401

  Tsunoda, Hiroyuki ^a,b   Hayakawa, Tomoko ^a   Sakuragawa, Norio ^b   Koyama, Hideki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

AAV plasmid; Integration junction; Linear plasmid; Lipofection; Site specific integration

Indexed keywords

ANTIBIOTIC G 418; HYGROMYCIN;

ADENO ASSOCIATED VIRUS; ARTICLE; EXPRESSION VECTOR; GENE EXPRESSION; GENE FUNCTION; GENE STRUCTURE; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; SOUTHERN BLOTTING; VIRUS CELL INTERACTION;

ADENO-ASSOCIATED VIRUS; DNA VIRUSES;

EID: 0034653522     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.0122     Document Type: Article

References (52)

1. Ashkotorab H., Srivastava A. Identification of nuclear type 2 inverted terminal repeat hairpin DNA. J. Virol. 63:1989;3034-3039.
2. Balague C., Kalla M., Zhang W. W. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol. 71:1997;3299-3306.
3. Bantel-Schaal U., Stohr M. Influence of adeno-associated virus on adherence and growth properties of normal cells. J. Virol. 66:1992;773-779.
4. Beaton A., Palumbo P., Berns K. I. Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J. Virol. 63:1989;4450-4454.
5. Berns K. I., Kotin R. M., Labow M. A. Regulation of adeno-associated virus DNA replication. Biochim. Biophys. Acta. 951:1988;425-429.
6. Bohenzky R. A., LeFebvre R. B., Berns K. I. Sequence and symmetry requirements within the internal palindromic sequences of the adeno-associated virus terminal repeat. Virology. 166:1988;316-327.
7. Dong J. Y., Fan P. D., Frizzell R. A. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7:1996;2101-2112.
8. Dyall J., Berns K. I. Site-specific integration of adeno-associated virus into an episome with the target locus via a deletion-substitution mechanism. J. Virol. 72:1998;6195-6198.
9. Flotte T. R., Afione S. A., Solow R., Drumm M. L., Markakis D., Guggino W. B., Zeltlin P. L., Carter B. J. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268:1993;3781-3790.
10. Folger K. R., Wong E. A., Wahl G., Capecchi M. R. Patterns of integration of DNA microinjected into cultured mammalian cells: Evidence for homologous recombination between injected plasmid DNA molecules. Mol. Cell. Biol. 2:1982;1372-1387.
11. Fujimaki K., Aratani Y., Fujisawa S., Motomura S., Okubo T., Koyama H. DNA topoisomerase II inhibitors enhance random integration of transfected vectors into human chromosomes. Somat. Cell Mol. Genet. 22:1996;279-290.
12. Giraud C., Winocour E., Berns K. I. Site-specific integration by adeno-associated virus is directed by a cellular DNA sequence. Proc. Natl. Acad. Sci. USA. 91:1994;10039-10043.
13. Giraud C., Winocour E., Berns K. I. Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome. J. Virol. 69:1995;6917-6924.
14. Gottlieb J., Muzyczka N. In vitro excision of adeno-associated virus DNA from recombinant plasmids: Isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences. Mol. Cell. Biol. 8:1988;2513-2522.
15. Im D.-S., Muzyczka N. Factors that bind to adeno-associated virus terminal repeats. J. Virol. 63:1989;3095-3104.
16. Im D.-S., Muzyczka N. The AAV origin binding protein rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell. 61:1990;447-457.
17. Kearns W. G., Afione S. A., Fulmer S. B., Pang M. C., Erikson D., Egan M., Landrum M. J., Flotte T. R., Cutting G. R. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3:1996;748-755.
18. Kotin R. M. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 5:1994;793-801.
19. Kotin R. M., Berns K. I. Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology. 170:1989;460-467.
20. Kotin R. M., Linden R. M., Berns K. I. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11:1992;5071-5078.
21. Kotin R. M., Menninger J. C., Ward D. C., Berns K. I. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics. 10:1991;831-834.
22. Kotin R. M., Siniscalco M., Samulski R. J., Zhu X. D., Hunter L., Laughlin C. A., McLaughlin S., Muzyczka N., Rocchi M., Berns K. I. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA. 87:1990;2211-2215.
23. Labow M. A., Berns K. I. The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. J. Virol. 62:1988;1705-1712.
24. Labow M. A., Hermonat P. L., Berns K. I. Positive and negative autoregulation of the adeno-associated virus type 2 genome. J. Virol. 60:1986;251-258.
25. Lamartina S., Roscilli G., Rinaudo D., Delmastro P., Toniatti C. Lipofection of purified adenovirus-associated virus rep68 protein: Toward a chromosome-targeting nonviral particle. J. Virol. 72:1998;7653-7658.
26. Laughlin C. A., Cardellichio C. B., Coon H. C. Latent infection of KB cells with adeno-associated virus type 2. J. Virol. 60:1986;515-524.
27. Ledley F. D. Nonviral gene therapy: The promise of genes as pharmaceutical products. Hum. Gene Ther. 6:1995;1129-1144.
28. Lefebvre R. B., Riva S., Berns K. I. Conformation takes precedence over sequence in adeno-associated virus DNA replication. Mol. Cell. Biol. 4:1984;1416-1419.
29. Linden R. M., Ward P., Giraud C., Winocour E., Berns K. I. Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA. 93:1996a;11288-11294.
30. Linden R. M., Winocour E., Berns K. I. The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. USA. 93:1996b;7966-7972.
31. McCarty D. M., Pereira D. J., Zolotukhin I., Zhou X., Ryan J. H., Muzyczka N. Identification of linear DNA sequences that specifically bind the adeno-associated virus rep protein. J. Virol. 68:1994;4988-4997.
32. McLaughlin S. K., Collis P., Hermonat P. L., Muzyczka N. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62:1988;1963-1973.
33. Muzyczka N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158:1992;97-129.
34. Palmiter R. D., Wilkie T. M., Chen H. Y., Brinster R. L. Transmission distortion and mosaicism in an unusual transgenic mouse pedigree. Cell. 36:1984;869-877.
35. Pieroni L., Fipaldini C., Monciotti A., Cimini D., Sgura A., Fattori E., Epifano O., Cortese R., Palombo F., Monica L. N. Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology. 249:1998;249-259.
36. Philip R., Brunette E., Kilinski L., Murugesh D., McNally M. A., Ucar K., Rosenblatt J., Okarma T. B., Lebkowski J. S. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol. Cell. Biol. 14:1994;2411-2418.
37. Ponnazhagan S., Erikson D., Kearns W. G., Zhou S. Z., Nahreini P., Wang X. S., Srivastava A. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum. Gene Ther. 8:1997;275-284.
38. Roth D., Wilson J. Illegitimate recombination in mammalian cells. Kucherlapati R., Smith G. R. Genetic Recombination. 1988;621-653 Am. Soc. Microbiol. Washington.
39. Rutledge E. A., Russell D. W. Adeno-associated virus vector integration junctions. J. Virol. 71:1997;8429-8436.
40. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Plainview.
41. Samulski R. J., Berns K. I., Tan M., Muzyczka N. Cloning of adeno-associated virus into pBR322: Rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl. Acad. Sci. USA. 79:1982;2077-2081.
42. Samulski R. J., Chang L.-S., Shenk T. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61:1987;3096-3101.
43. Samulski R. J., Chang L. S., Shenk T. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression. J. Virol. 63:1989;3822-3828.
44. Samulski R. J., Zhu X., Xiao X., Brook J. D., Housman D. E., Epstein N., Hunter L. A. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:1991;394-3950.
45. Shelling A. N., Smith M. G. Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene. Gene Ther. 1:1994;165-169.
46. Srivastava A., Lusby E. W., Berns K. I. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45:1983;555-564.
47. Surosky R. T., Urabe M., Godwin S. G., McQuiston S. A., Kurtzman G. J., Ozawa K., Natsoulis G. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol. 71:1997;7951-7959.
48. Urcelay E., Ward P., Wiener S. M., Safer B., Kotin R. M. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus rep protein. J. Virol. 69:1995;2038-2046.
49. Ward P., Berns K. I. In vitro rescue of an integrated hybrid adeno-associated virus/simian virus 40 genome. J. Mol. Biol. 218:1991;791-804.
50. Weitzman M. D., Kyostio S. R. M., Kotin R. M., Owens R. A. Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV and its integration site in human DNA. Proc. Natl. Acad. Sci. USA. 91:1994;5808-5812.
51. Yang C. C., Xiao X., Zhu X., Ansardi D. C., Epstein N. D., Frey M. R., Matera A. G., Samulski R. J. Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71:1997;9231-9247.
52. Yang Q., Chen F., Trempe J. P. Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J. Virol. 68:1994;4847-4856.